Tag Archive | "co-development"

FORMA reels in Johnson & Johnson Janssen Biotech with $700 million deal

Tags: , , , , ,

FORMA Therapeutics announced an exclusive alliance with Janssen Biotech in which the two companies will collaborate on the discovery, development and commercialization of novel small molecule drug candidates that target tumor metabolism mechanisms.  Read the full story

AstraZeneca and Hutchison MediPharma enter into global licensing, co-development, and commercialisation agreement for Volitinib

Tags: , , , ,

AstraZeneca and Hutchison MediPharma have entered into a global licensing, co-development, and commercialisation agreement for Volitinib (HMPL-504), a novel targeted therapy and a highly selective inhibitor of the c-Met receptor tyrosine kinase for the treatment of cancer.  Read the full story

AgonOx partners with MedImmune for development of OX40 agonists in cancer therapy

Tags: ,

Exclusive global partnership with MedImmune to develop agonists using its OX40 platform.  Read the full story

Merck KGaA / Ono: Co-development and co-marketing agreement for Stimuvax

Tags: , , , ,

Merck and Ono Pharmaceutical form collaborations to develop oral Multiple Sclerosis drug and cancer immunotherapy.  Read the full story

Co-development, licensing and co-promotion agreement for Orencia

Tags: , , , , ,

Bristol-Myers Squibb and Ono Pharmaceutical will co-develop and co-commercialize ORENCIA, a biologic therapy for rheumatoid arthritis, in Japan.  Read the full story